
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
SPEN CRISPR/Cas9 KO Plasmid (h) | sc-406083 | 20 µg | $397.00 |
SPEN (also known as SHARP) encodes a large nuclear RNA-binding transcriptional coregulator that couples sequence-specific DNA-binding partners and long noncoding RNAs to chromatin-modifying complexes. Through interactions with SMRT/HDAC and related repressors, SPEN contributes to transcriptional silencing programs, including XIST-dependent X-chromosome inactivation, and influences lineage-specific gene expression. SPEN also modulates signaling-responsive transcriptional outputs, with reported connections to Notch-associated regulation and broader epigenetic control of developmental and immune-related pathways. Dysregulated SPEN function or expression has been implicated in altered differentiation states and transcriptional rewiring observed across multiple disease contexts, supporting its utility as a mechanistic node in gene regulation studies.
SPEN CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the SPEN gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the SPEN together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the SPEN open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish SPEN protein expression.
This CRISPR knockout system enables efficient generation of SPEN-deficient cell models for investigation of SPEN signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.